FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

37228711000001100: Co-beneldopa 12.5mg/50mg capsules (DE Pharmaceuticals) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 12-Jun 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
232881000001119 Co-beneldopa 12.5mg/50mg capsules (DE Pharmaceuticals) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
232891000001117 Co-beneldopa 12.5mg/50mg capsules (DE Pharmaceuticals) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Co-beneldopa 12.5mg/50mg capsules (DE Pharmaceuticals) Is a Product containing precisely benserazide 12.5 milligram and levodopa 50 milligram/1 each conventional release oral capsule (clinical drug) true Inferred relationship Existential restriction modifier
Co-beneldopa 12.5mg/50mg capsules (DE Pharmaceuticals) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Co-beneldopa 12.5mg/50mg capsules (DE Pharmaceuticals) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Co-beneldopa 12.5mg/50mg capsules (DE Pharmaceuticals) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Co-beneldopa 12.5mg/50mg capsules (DE Pharmaceuticals) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Benserazide true Inferred relationship Existential restriction modifier
Co-beneldopa 12.5mg/50mg capsules (DE Pharmaceuticals) Has specific active ingredient Benserazide hydrochloride true Inferred relationship Existential restriction modifier
Co-beneldopa 12.5mg/50mg capsules (DE Pharmaceuticals) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Co-beneldopa 12.5mg/50mg capsules (DE Pharmaceuticals) Has specific active ingredient Levodopa true Inferred relationship Existential restriction modifier
Co-beneldopa 12.5mg/50mg capsules (DE Pharmaceuticals) Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
Co-beneldopa 12.5mg/50mg capsules (DE Pharmaceuticals) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Co-beneldopa 12.5mg/50mg capsules (DE Pharmaceuticals) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Co-beneldopa 12.5mg/50mg capsules (DE Pharmaceuticals) 100 capsule Has AMP True Co-beneldopa 12.5mg/50mg capsules (DE Pharmaceuticals) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start